
Episode 1: UEG Journal May spotlight
GI pearls from the latest literature published in UEGJ
GI pearls from the latest literature published in UEGJ
Ahsen Ustaoglu interviews Dr Celia Escudero-Hernandez on their transcriptomic study delving into the pathogenesis of lymphocytic colitis, where they identified two subtypes of lymphocytic colitis: channelopathic and inflammatory lymphocytic colitis, which could pave the way for novel biomarkers and therapeutic avenues.
In this episode, Ahsen Ustaoglu interviews Prof Vincent Wong on their comprehensive review of non-invasive biomarkers and imaging tools for non-alcoholic fatty liver disease which has a rapidly rising incidence worldwide.
Ahsen Ustaoglu interviews Dr Mathias Brugel on their targeted screening analysis of pancreatic adenocarcinoma risk with organoclorine pesticides from the PESTIPAC study
In this episode, Dr. Tarik Kani interviews Dr Christian Agboton from USA about the optimal position of Vedolizumab in long-term Crohn's Disease
Join Ahsen Ustaoglu and H. Tarik Kani as they interview Dr Asa Frandemark on their study investigating work impairment in disorders of gut-brain interactions which assessed retrospective data from the Rome Foundation Global Epidemiology Study
In this episode, Dr. Tarik Kani interviews Dr Milou van Riswijk from The Netherlands about a new bowel cleansing system which was designed to overcome an important issue for endoscopists and patients.
In this episode, Ahsen Ustaoglu interviews Dr Raul Velamazan to discuss their findings from the multicentre RELAPSTONE study on recurrence patterns and risk factors for relapse after first admission of patients with symptomatic gallstone disease
Dr. Tarik Kani interviews Dr Alberto Zanetto from Italy, on their study which they were created a new model to predict acute-on-chronic liver failure in decompensated cirrhosis.
Dr Ahsen Ustaoglu interviews Dr Rajan Singh and Dr Hannah Zogg from the University of Nevada, USA, on their study which investigated the role of microRNA 10b-5p in regulating gut barrier function in an in vivo model of diabetes and gastrointestinal dysmotility, important mechanistic work in the field of Neurogastroenterology.
1/4
Next page